Immuron (IMRN) Capital Expenditures (2016 - 2022)
Immuron (IMRN) posted Capital Expenditures of $7067.0 for Q4 2022, up 245.61% on a QoQ basis from -$4853.3 in Q4 2021, and up 245.61% year-over-year from $2044.8 in Q4 2021.
Powered by 
Analysis
Immuron (IMRN) Capital Expenditures (2016 - 2022) Analysis & Trends
Immuron has reported Capital Expenditures for 6 years, with the latest figure at $7067.0 in Q4 2022.
- On a quarterly basis, Capital Expenditures rose 245.61% year-over-year to $7067.0 in Q4 2022; TTM through Dec 2022 was -$5280.3, a 62.35% increase from a year earlier, with the FY2026 full-year figure at -$4752.0, changed N/A from the prior year.
- Capital Expenditures was $7067.0 for Q4 2022 at Immuron, up from -$4853.3 in the prior quarter.
- The five-year high for Capital Expenditures was $7067.0 in Q4 2022, with the low at -$6630.0 in Q4 2020.
- Average Capital Expenditures over 4 years is -$1320.1, with a median of -$2858.6 recorded in 2019.
- The sharpest annual moves came in 2020 and 2022: Capital Expenditures tumbled 667.36% in 2020, then surged 245.61% in 2022.
- Over 4 years, Capital Expenditures stood at -$864.0 in 2019, then sank by 667.36% to -$6630.0 in 2020, then advanced by 26.8% to -$4853.3 in 2021, then soared by 245.61% to $7067.0 in 2022.
- The last three Capital Expenditures figures came in at $7067.0 (Q4 2022), -$4853.3 (Q4 2021), and -$6630.0 (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 37.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -1.87 Mn |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 7,067.00 |
| Dec 31, 2021 | -4,853.28 |
| Dec 31, 2020 | -6,630.00 |
| Dec 31, 2019 | -864.00 |
| Dec 31, 2017 | -1,676.50 |
| Dec 31, 2016 | 1,416.72 |
API Access
Immuron Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();